Are you able to provide me some references of drugs skipping trials? I am interested in reading up on it. It would be a pretty big deal for RCE to skip trials and most likely great for us shareholders but seems a little bit of a stretch given the drug itself RECCE 327 is a new type of drug, that being synthetic polymer based antibiotic, hopefully we find out soon!
Accelerated Approval for RECCE® 327, page-6
-
- There are more pages in this discussion • 89 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $102.0M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30417 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 25000 | 1 |
View Market Depth
| Last trade - 10.02am 06/08/2024 (20 minute delay) ? |
| RCE (ASX) Chart |
Day chart unavailable